Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
Posted inDrugs (Pharmaceuticals) Eli Lilly and Company Food and Drug Administration GLP-1 RAs (Drug) Hims & Hers Health Inc Jorgensen, Lars Fruergaard Makary, Marty Novo Nordisk A/S Obesity Prices (Fares, Fees and Rates) Shortages Telemedicine Weight

Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.